02.06.2013 Views

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Reactions<br />

Skin<br />

Erythema multiforme<br />

Pruritus (13%)<br />

(2004): Young TM+, Ann Pharmacother 38(11), 1868<br />

(1998): McClellan KJ+, <strong>Drug</strong>s Aging 12(1), 76<br />

(1993): Jankovic J+, Am J Med 95(1), 38 (scalp) (13.5%)<br />

Rash (sic) (2.4%)<br />

Xerosis (2%)<br />

Mucosal<br />

Aphthous stomatitis<br />

Xerostomia (1–10%)<br />

Hair<br />

Hair – pili torti<br />

(1998): McClellan KJ+, <strong>Drug</strong>s Aging 12(1), 76<br />

(1989): McTavish D+, <strong>Drug</strong>s 38(5), 757<br />

Other<br />

Chills (5%)<br />

Pain (5%)<br />

MIFEPRISTONE<br />

Synonym: RU-486<br />

Trade name: Mifeprex (Danco)<br />

Indications: Medical termination of intrauterine pregnancy<br />

Category: Corticosteroid antagonist; Progestogen antagonist<br />

Half-life: ~20 hours<br />

Reactions<br />

Mucosal<br />

Vaginitis (3%)<br />

Other<br />

Abdominal pain (89%)<br />

(2003): Piaggio G+, Contraception 68(6), 439<br />

(2002): Tang OS+, Hum Reprod 17(7), 1738 (89%) (with<br />

misoprostol)<br />

Chills (3–38%)<br />

(2002): Tang OS+, Hum Reprod 17(7), 1738 (38%) (with<br />

misoprostol)<br />

Fever (79%)<br />

(2002): Tang OS+, Hum Reprod 17(7), 1738 (79%) (with<br />

misoprostol)<br />

Infections<br />

(2001): DeHart RM+, Ann Pharmacother 35(6), 707<br />

MIGLITOL<br />

Trade name: Glyset (Pfizer)<br />

Indications: Non-insulin dependent diabetes type ll<br />

Category: Alpha-glucosidase inhibitor<br />

Half-life: ~2 hours<br />

Skin<br />

Rash (sic) (1–10%)<br />

Reactions<br />

Other<br />

Abdominal pain<br />

(2002): Drent ML+, Diabetes Nutr Metab 15(3), 152<br />

(2000): Campbell LK+, Ann Pharmacother 34(11), 1291<br />

(2000): Scott LJ+, <strong>Drug</strong>s 59(3), 521<br />

MIGLUSTAT<br />

Trade name: Zavesca (Actelion)<br />

Indications: Gaucher’s disease<br />

Category: Glucosylceramide synthase inhibitor<br />

Half-life: 6–7 hours<br />

Reactions<br />

Skin<br />

Burning (h<strong>and</strong>s & feet)<br />

Mucosal<br />

Xerostomia (8%)<br />

Other<br />

Abdominal pain (50%)<br />

Neurotoxicity<br />

(2005): Prescrire Int 14(79), 168 (19%)<br />

MILK THISTLE*<br />

Scientific names: Carduus marainum; Silibum marianum<br />

Family: Asteraceae; Compositae<br />

Trade <strong>and</strong> other common names: Holy Thistle; Lady’s<br />

Thistle; Marian Thistle; Mary Thistle; Silymarin<br />

Category: Immunomodulator<br />

Purported indications <strong>and</strong> other uses: Dyspepsia, liver<br />

protectant, hepatitis, loss of appetite, spleen diseases, supportive<br />

treatment for mushroom poisoning<br />

Half-life: N/A<br />

Reactions<br />

Skin<br />

Adverse effects (sic)<br />

(2000): Evid Rep Technol p(21), 1<br />

(1999): No Author, Med J Aust 170(5), 218<br />

Allergic reactions (sic)<br />

Diaphoresis<br />

Rash (sic)<br />

(2001): Saller R+, <strong>Drug</strong>s 61(14), 2035<br />

Urticaria<br />

(1990): Mironets VI+, Vrach Delo 7, 86<br />

*Note: Seed as opposed to the ‘aboveground parts’<br />

MILK THISTLE 367

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!